Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial cell membranes and biofilms are not a single molecular target but refer to structural and functional assemblies produced by microorganisms. The microbial cell membrane is a lipid bilayer with embedded proteins that controls the passage of molecules and interacts with the external environment. A biofilm is a structured community of microbial cells encased within a self-produced extracellular polymeric substance (EPS) matrix adhered to biotic or abiotic surfaces. Biofilm formation involves initial adhesion, microcolony formation, maturation, and eventual dispersion of cells[1][2][3][5]. The EPS matrix contains polysaccharides, proteins (such as enzymes and fimbriae), extracellular DNA and lipids, providing cohesion, protection, and a medium for cell–cell communication and horizontal gene transfer[1][2][3][4]. Biofilms protect microorganisms from host immune responses, dehydration, oxidizing agents, and antimicrobial drugs, making infections notoriously difficult to treat and leading to chronic diseases and medical device failures[1][2][5][6]. Drugs targeting biofilms often work by disrupting the matrix, inhibiting EPS synthesis or communication pathways essential for biofilm integrity. The term is broad, referring to a microbial community attribute, not a precise protein, receptor, or enzyme, which lowers its specificity as a molecular therapeutic target.
Disruption of biofilm matrix (enzymatic degradation, chelation); Increased membrane permeability or disruption; Inhibition of extracellular polymeric substance (EPS) synthesis; Inhibition of cell–cell communication (quorum sensing inhibitors)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cell membrane and biofilm.